We are live on ! Find out more
MYIA

Mount Yale Investment Advisors Portfolio holdings

AUM $4.31B
1-Year Est. Return 21.13%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+21.13%
3 Year Est. Return
+69.37%
5 Year Est. Return
+92.43%
10 Year Est. Return
AUM
$881M
AUM Growth
+$128M
Cap. Flow
+$74.6M
Cap. Flow %
8.47%
Top 10 Hldgs %
26.29%
Holding
501
New
59
Increased
176
Reduced
198
Closed
49

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.39M
2
MRK icon
Merck
MRK
+$6.96M
3
ORCL icon
Oracle
ORCL
+$5.88M
4
T icon
AT&T
T
+$4.69M
5
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$2.75M

Sector Composition

Rank Sector Weight
1 Technology 23.19%
2 Healthcare 10.44%
3 Financials 9.49%
4 Consumer Discretionary 6.9%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
51
AstraZeneca
AZN
$250B
$4.49M 0.51%
33,101
+2,175
+7% +$273K
PGR icon
52
Progressive
PGR
$125B
$4.41M 0.5%
33,969
-1,149
-3% -$146K
AON icon
53
Aon
AON
$76B
$4.37M 0.5%
14,546
+116
+0.8% +$33.9K
IWM icon
54
iShares Russell 2000 ETF
IWM
$81.9B
$4.31M 0.49%
24,695
-2,038
-8% -$362K
XLF icon
55
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$4.29M 0.49%
125,374
+28,619
+30% +$968K
SWK icon
56
Stanley Black & Decker
SWK
$15.7B
$4.27M 0.48%
56,828
-10,768
-16% -$840K
INTC icon
57
Intel
INTC
$513B
$4.15M 0.47%
157,188
-45,399
-22% -$1.26M
IJK icon
58
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$3.93M 0.45%
+57,546
New +$3.96M
ABBV icon
59
AbbVie
ABBV
$435B
$3.91M 0.44%
24,193
-462
-2% -$70.8K
NVO
60
Novo Nordisk
NVO
$209B
$3.88M 0.44%
57,406
+480
+0.8% +$28.1K
C icon
61
Citigroup
C
$226B
$3.87M 0.44%
85,607
-39,556
-32% -$1.8M
DGRO icon
62
iShares Core Dividend Growth ETF
DGRO
$43.6B
$3.86M 0.44%
+77,195
New +$3.79M
CP icon
63
Canadian Pacific Kansas City
CP
$80.5B
$3.77M 0.43%
50,484
+197
+0.4% +$14.8K
HD icon
64
Home Depot
HD
$355B
$3.67M 0.42%
11,628
-74
-0.6% -$22.5K
CTSH icon
65
Cognizant
CTSH
$26B
$3.59M 0.41%
62,811
-35,297
-36% -$2.07M
MRK icon
66
Merck
MRK
$318B
$3.56M 0.4%
32,079
-68,071
-68% -$6.96M
ASML icon
67
ASML
ASML
$669B
$3.46M 0.39%
6,329
-1,877
-23% -$983K
GLD icon
68
SPDR Gold Trust
GLD
$142B
$3.44M 0.39%
20,280
V icon
69
Visa
V
$677B
$3.33M 0.38%
16,042
-1,604
-9% -$323K
QQQ icon
70
Invesco QQQ Trust
QQQ
$481B
$3.32M 0.38%
12,456
+179
+1% +$49.5K
IJH icon
71
iShares Core S&P Mid-Cap ETF
IJH
$127B
$3.29M 0.37%
68,105
-4,000
-6% -$193K
GS icon
72
Goldman Sachs
GS
$303B
$3.19M 0.36%
9,281
-114
-1% -$39.7K
RMD icon
73
ResMed
RMD
$30.7B
$3.15M 0.36%
15,140
-45
-0.3% -$9.89K
IBM icon
74
IBM
IBM
$224B
$3.1M 0.35%
22,006
-614
-3% -$84.7K
RACE icon
75
Ferrari
RACE
$72.5B
$3.02M 0.34%
14,094
+93
+0.7% +$19.2K

Similar funds

Mount Yale Investment Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Mount Yale Investment Advisors held 501 positions worth $881M, up 17% from $753M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mount Yale Investment Advisors deployed $74.6M of net new capital in Q4 2022, opening 59 new positions and adding to 176 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 243,627 shares worth $11.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $6.96M trimmed.

  • Mount Yale Investment Advisors's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 243,627 shares worth $11.1M.
  • Mount Yale Investment Advisors added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $8.04M increase.
  • Mount Yale Investment Advisors's biggest Q4 2022 reduction was Merck, cutting an estimated $6.96M.
  • Mount Yale Investment Advisors fully exited Gilead Sciences in Q4 2022, selling an estimated $7.39M.
  • Mount Yale Investment Advisors's ten largest holdings make up 26% of its $881M portfolio in Q4 2022.
  • Mount Yale Investment Advisors opened 59 new positions and closed 49 in Q4 2022.
  • Mount Yale Investment Advisors's portfolio value rose 17% quarter-over-quarter to $881M.

Based on Mount Yale Investment Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.